摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N'-(benzenesulfonyl)-1-phenacylpyridin-1-ium-3-carbohydrazide

中文名称
——
中文别名
——
英文名称
N'-(benzenesulfonyl)-1-phenacylpyridin-1-ium-3-carbohydrazide
英文别名
——
N'-(benzenesulfonyl)-1-phenacylpyridin-1-ium-3-carbohydrazide化学式
CAS
——
化学式
C20H18N3O4S+
mdl
——
分子量
396.4
InChiKey
PZPGCMOMEVPATR-UHFFFAOYSA-O
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    28
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.05
  • 拓扑面积:
    105
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
    申请人:TORRENT PHARMACEUTICALS LTD.
    公开号:US20030092744A1
    公开(公告)日:2003-05-15
    The invention discloses novel compounds of the pyridinium series useful for the management of diabetes and aging-related vascular complications, including kidney disease, nerve damage, atherosclerosis, retinopathy, dermatological disorders and discoloration of teeth, by breaking preformed AGE, of the general formula I, or pharmaceutically acceptable salts thereof, 1 wherein, R 1 , R 2 , R 3 , X and m are as defined in the specification. The invention also discloses, method for preparation of the novel compounds of the series and pharmaceutical composition having one or more compounds as defined above as active ingredients. The invention further discloses a method of treatment of a diabetic patient by administering the compounds as defined above, either singly or in combination with drugs for antidiabetic therapy.
    本发明公开了新型吡啶系列化合物,通过打破通式 I 的预形成 AGE 或其药学上可接受的盐,可用于治疗糖尿病和与衰老相关的血管并发症,包括肾病、神经损伤、动脉粥样硬化、视网膜病变、皮肤病和牙齿变色、 1 其中,R 1 , R 2 , R 3 X 和 m 如说明书中所定义。 本发明还公开了本系列新型化合物的制备方法和以一种或多种如上定义的化合物为活性成分的药物组合物。 本发明进一步公开了一种治疗糖尿病患者的方法,通过单独施用或与抗糖尿病治疗药物联合施用上述定义的化合物。
  • PYRIDINIUM DERIVATIVES FOR THE MANAGEMENT OF AGING-RELATED AND DIABETIC VASCULAR COMPLICATIONS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF
    申请人:Torrent Pharmaceuticals Ltd
    公开号:EP1222171A1
    公开(公告)日:2002-07-17
  • [EN] PYRIDINIUM DERIVATIVES FOR THE MANAGEMENT OF AGING-RELATED AND DIABETIC VASCULAR COMPLICATIONS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF<br/>[FR] NOUVEAUX COMPOSES UTILES POUR TRAITER LES COMPLICATIONS VASCULAIRES LIEES A L'AGE ET AU DIABETE, PROCEDE DE PREPARATION ET UTILISATIONS THERAPEUTIQUES DE CES COMPOSES
    申请人:SANKARANARAYANAN ALANGUDI
    公开号:WO2001025208A1
    公开(公告)日:2001-04-12
    The invention discloses novel compounds of the pyridinium series useful for the management of diabetes and aging-related vascular complications, including kidney disease, nerve damage, atherosclerosis, retinopathy, dermatological disorders and discoloration of teeth, by breaking preformed AGE, of general formula (I), or pharmaceutically acceptable salts thereof, wherein, R1, R2, R3, X and m are as defined in the specification. The invention also discloses, method for preparation of the novel compounds of the series and pharmaceutical composition having one or more compounds as defined above as active ingredients. The invention further discloses a method of treatment of a diabetic patient by administering the compounds as defined above, either singly or in combination with drugs for antidiabetic therapy.
查看更多